Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Klinger Shannon ThymeChief Legal Officer | Option exercise | M | — 774 sh | Aug 31, 2026 |
| 17 | Courtney Mark RVice President of Supply Chain | Option exercise | M | — 2,997 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 17 | Eddy ShalevDirector | Open-market sale | SELL | $29K 900 sh | Aug 31, 2026 traded Aug 28, 2026 |
| 17 | Hoge StephenPresident | Option exercise | M | — 1,437 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 17 | Knaggs David H.EVP of Quality and IS | Option exercise | M | — 5,995 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 17 | O'Grady Rebecca LDirector | Grant or award | A | — 4,125 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 16 | Beggs JillDirector | Open-market sale · 10b5-1 plan | SELL | $40K 2,307 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 16 | Iannone RobertEVP, Global Head of R&D & CMO | Option exercise · 10b5-1 plan | M | $3.78M 27.6K sh | Aug 31, 2026 traded Aug 27, 2026 |
| 16 | Ofman Joshua J.Director, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $425K 5,000 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 16 | Iannone RobertEVP, Global Head of R&D & CMO | Option exercise · 10b5-1 plan | M | $2.95M 26.1K sh | Aug 31, 2026 traded Aug 27, 2026 |
| 16 | Freidin AaronChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $672K 7,900 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $89K 10.0K sh | Aug 31, 2026 traded Aug 27, 2026 |
| 15 | Bonnell Brian MichaelChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $792K 4,568 sh | Aug 31, 2026 traded Aug 31, 2026 |
| 15 | Schlosser MarioDirector | Option exercise | M | $1.46M 150.0K sh | Aug 31, 2026 traded Aug 28, 2026 |
| 15 | Winspear Robert LChief Financial Officer | Grant or award | A | — 30.0K sh | Aug 31, 2026 traded Aug 25, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $281K 1,240 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 14 | Schlosser MarioDirector | Derivative conversion | C | — 600.0K sh | Aug 31, 2026 traded Aug 27, 2026 |
| 14 | Cohen Ariel M.Director, Chairperson and CEO | Open-market sale · 10b5-1 plan | SELL | $5.08M 168.4K sh | Aug 31, 2026 traded Aug 27, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $343K 1,520 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 14 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $383K 1,720 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 14 | Schlosser MarioDirector | Derivative conversion | C | — 600.0K sh | Aug 31, 2026 traded Aug 27, 2026 |
| 13 | Coley TammyDirector | Grant or award | A | $28K 177 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 13 | Iannone RobertEVP, Global Head of R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $76K 300 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 13 | Hasani RamiEVP, Chief Financial Officer | Tax withholding | F | $3,457 2,320 sh | Aug 31, 2026 traded Aug 28, 2026 |
| 13 | Coley TammyDirector | Grant or award | A | $36K 145 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 13 | Griffin BobbyDirector | Grant or award | A | — 409 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 13 | Motsenbocker AnneDirector | Grant or award | A | — 409 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 12 | Mock James MChief Financial Officer | Tax withholding | F | $56K 375 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 12 | Klinger Shannon ThymeChief Legal Officer | Tax withholding | F | $56K 375 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 12 | Hoge StephenPresident | Tax withholding | F | $104K 695 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 11 | Liu GeneChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $178K 939 sh | Aug 31, 2026 traded Aug 28, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $168K 760 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $105K 480 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $241K 1,080 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $71K 320 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $207K 920 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $191K 840 sh | Aug 31, 2026 traded Aug 27, 2026 |
| 11 | Bonnell Brian MichaelChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $293K 1,712 sh | Aug 31, 2026 traded Aug 31, 2026 |
| 11 | Bonnell Brian MichaelChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $329K 1,914 sh | Aug 31, 2026 traded Aug 31, 2026 |
| 11 | Kurtz GeorgeDirector, PRESIDENT AND CEO | Open-market sale · 10b5-1 plan | SELL | $64K 280 sh | Aug 31, 2026 traded Aug 27, 2026 |